Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Urowitz

Showing results (71-80 of 212) with videos related to

Pageof 22
Sort By:
Archives of Internal Medicine|July 1, 1988
Successful pregnancy in systemic lupus erythematosus with an untreated lupus anticoagulantF J Stafford-Brady, D D Gladman, M B Urowitz
The Journal of Rheumatology|February 24, 2000
Accurately describing changes in disease activity in Systemic Lupus ErythematosusD D Gladman, M B Urowitz, A Kagal, et al.
The Journal of Rheumatology|February 7, 1998
Hormone replacement therapy in systemic lupus erythematosusS Kreidstein, M B Urowitz, D D Gladman, et al.
Lupus|September 19, 2009
Variability and correlates of high sensitivity C-reactive protein in systemic lupus erythematosusM Nikpour, D D Gladman, D Ibañez, et al.
Lupus|July 18, 2012
SLEDAI-2K Responder Index 50 captures 50% improvement in disease activity over 10 yearsZ Touma, D D Gladman, D Ibañez, et al.
Lupus|June 5, 2002
The nature and outcome of infection in systemic lupus erythematosusD D Gladman, F Hussain, D Ibañez, et al.
Lupus|January 15, 2011
SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluationZ Touma, M B Urowitz, D Ibañez, et al.
Canadian Medical Association Journal|January 1, 1982
Prostaglandin E1 therapy for digital ulcers in sclerodermaM Baron, G Skrinskas, M B Urowitz, et al.
The Journal of Rheumatology|December 1, 1994
Serologically active clinically quiescent systemic lupus erythematosus--predictors of clinical flaresB A Walz LeBlanc, D D Gladman, M B Urowitz
Lupus|September 1, 2017
Sustained complete renal remission is a predictor of reduced mortality, chronic kidney disease and end-stage renal disease in lupus nephritisR Pakchotanon, D D Gladman, J Su, et al.
Pageof 22

Showing results (71-80 of 212) with videos related to

Sort By:
Pageof 22
Archives of Internal Medicine|July 1, 1988
Successful pregnancy in systemic lupus erythematosus with an untreated lupus anticoagulantF J Stafford-Brady, D D Gladman, M B Urowitz
The Journal of Rheumatology|February 24, 2000
Accurately describing changes in disease activity in Systemic Lupus ErythematosusD D Gladman, M B Urowitz, A Kagal, et al.
The Journal of Rheumatology|February 7, 1998
Hormone replacement therapy in systemic lupus erythematosusS Kreidstein, M B Urowitz, D D Gladman, et al.
Lupus|September 19, 2009
Variability and correlates of high sensitivity C-reactive protein in systemic lupus erythematosusM Nikpour, D D Gladman, D Ibañez, et al.
Lupus|July 18, 2012
SLEDAI-2K Responder Index 50 captures 50% improvement in disease activity over 10 yearsZ Touma, D D Gladman, D Ibañez, et al.
Lupus|June 5, 2002
The nature and outcome of infection in systemic lupus erythematosusD D Gladman, F Hussain, D Ibañez, et al.
Lupus|January 15, 2011
SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluationZ Touma, M B Urowitz, D Ibañez, et al.
Canadian Medical Association Journal|January 1, 1982
Prostaglandin E1 therapy for digital ulcers in sclerodermaM Baron, G Skrinskas, M B Urowitz, et al.
The Journal of Rheumatology|December 1, 1994
Serologically active clinically quiescent systemic lupus erythematosus--predictors of clinical flaresB A Walz LeBlanc, D D Gladman, M B Urowitz
Lupus|September 1, 2017
Sustained complete renal remission is a predictor of reduced mortality, chronic kidney disease and end-stage renal disease in lupus nephritisR Pakchotanon, D D Gladman, J Su, et al.
Pageof 22